Skip to main content

This new guidance has been issued jointly by the Department of Health and Social Care (DHSC), Public Health Wales (PHW), Public Health Agency (PHA) Northern Ireland, Health Protection Scotland (HPS)/National Services Scotland, Public Health England (PHE) and NHS England and is classified as official guidance. 

As such it is our expectation that registrants review the guidance carefully and implement any necessary changes. We expect that registrants will already be adhering to the infection prevention and control measures previously set out. However, the care pathway assessment in the guidance indicates that it is likely that for most patients receiving direct care a visor must be worn.

We draw particular attention to the categories of risk and applicable requirements in relation to PPE (The high-risk pathway is not applicable to care provided by chiropractors).

The relevant care pathway for some chiropractic patients may be LOW risk: Any care facility where: 

a)    triaged/clinically assessed individuals with no symptoms or known recent COVID-19 contact who have isolated/shielded AND have a negative SARS-CoV-2 (COVID-19) test within 72 hours of treatment and, for planned admissions, have self-isolated from the test date 

OR 

b)    individuals who have recovered from COVID-19 and have had at least 3 consecutive days without fever or respiratory symptoms and a negative COVID-19 test. The PPE requirements are set out in Section 7.2 – as follows: 

The relevant care pathway for most chiropractic patients is likely to be MEDIUM risk: Any care facility where: 

a)    triaged/clinically assessed individuals are asymptomatic and are waiting for a SARS-CoV-2 (COVID-19) test result with no known recent COVID-19 contact 

OR 

b)    testing is not required or feasible on asymptomatic individuals and infectious status is unknown. The PPE requirements are set out in Section 9.2 – as follows:

For the medium risk pathway, which we expect will apply to most patients receiving direct care, a visor must be worn. 

Registrants are expected to consider this new guidance in their risk assessments of treating patients.

Please note: We are advised by the authors the sample triage tool at Appendix 1 is indicative, and that the main text within the guidance has primacy. Therefore, the prospective patient needs to have a negative SARS-CoV2 result before being able to be considered in the low-risk category.